Clinical trial · Observational
Cancer Chronic Pain Predicted by Emotional and Cognitive Status
NCT02777697CI-TRIAL-00044418CanoPEecompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to investigate the predictive dimension of cognitive-emotional status of cancer patients on the chronic pain development 6 months after different cancer treatment protocol (surgery, chemotherapy, radiotherapy, hormone therapy, targeted therapy ...).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Chronic Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| chronic pain | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- cancer patients
- interventionNames
- Other: chronic pain
Primary outcomes (1)
- measure
- Measure of average pain intensity by a numerical rating scale
- timeFrame
- 7 days before the visit
- description
- Measure of average pain intensity by a numerical rating scale assessed 7 days before the 6 months visit after inclusion of patients.
Secondary outcomes (19)
- measure
- Pain assessment by numerical rating scale and DN4
- timeFrame
- at baseline
- measure
- Pain assessment by numerical rating scale and DN4
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 years * Cancer patient with one or more programmed cancer treatment protocols (chemotherapy, surgery, hormone therapy, radiation therapy, targeted therapy, ...) * Acceptance to sign the non-opposition form Exclusion Criteria: * History of cancer and cancer treatment protocols (chemotherapy, surgery, hormone therapy, radiation therapy, targeted therapy, ...) * History and/or presence of primary brain tumors (glioblastoma, meningioma, neurofibroma ...) * History of neurological disorders (Parkinson's disease, Alzheimer's disease, dementia, epilepsy, moderate to severe head injury, ...) * History of psychiatric disorders (schizophrenia, bipolar disorder, ...) * Medical and surgical history incompatible with the study
References
Publications (0)
Data not yet available
No reference posted for this study.